Table 3 Distribution of mitochondrial haplotypes in study groups
From: The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Variable | Normal liver histology (N = 94) | Non-NASH NAFLD (N = 143) | NASH (N = 104) | P value* | P-value†| P value‡ |
|---|---|---|---|---|---|---|
Haplotype | ||||||
 H | 28 (29.8 %) | 56 (39.2 %) | 37 (35.6 %) | 0.1400 | 0.3863 | 0.5660 |
 L | 23 (24.5 %) | 22 (15.4 %) | 6 (5.8 %) | 0.0811 | 0.0002 | 0.0186 |
 U | 11 (11.7 %) | 14 (9.8 %) | 17 (16.3 %) | 0.6393 | 0.3490 | 0.1247 |
 K | 8 (8.5 %) | 12 (8.4 %) | 11 (10.6 %) | 0.9743 | 0.6221 | 0.5595 |
 J | 11 (11.7 %) | 11 (7.7 %) | 5 (4.8 %) | 0.2980 | 0.0755 | 0.3631 |
 T | 6 (6.4 %) | 9 (6.3 %) | 6 (5.8 %) | 0.9780 | 0.8566 | 0.8647 |
 Other | 4 (4.3 %) | 13 (9.1 %) | 18 (17.3 %) | 0.1582 | 0.0035 | 0.0543 |